Journal of Agriculture & Life Sciences

Mini Review Study of Antitubercular Drugs of Nicotinamide, Thioisonicotinamide and Pyrazinamide Derivatives
Mohammad Asif

Abstract
The tuberculosis is a typically chronic infection caused by Mycobacterium tuberculosis. The progress of effective treatment of tuberculosis (TB) has been recently due to alarm regarding the appearance of vastly drug-resistant TB strains. The efforts that gave rise to current first line and second-line anti-TB drugs in global use today and attempts to summarize ongoing discovery being conducted. The TB has different disease-specific concerns and control that introduce major complexity in drug discovery efforts. In this article a brief discussion about nicotinamide, thioisonicotinamide and pyrazinamide analogues for the better and effect TB treatment particular against resistance mycobacterium strains.

Full Text: PDF